Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. GlaxoSmithKline LLC
EIR
•GlaxoSmithKline LLC•August 9, 2012

GlaxoSmithKline LLC – FDA EIR, Aug 9, 2012

Record Details

An FDA inspection of GlaxoSmithKline, Inc.'s nonclinical research laboratory in Durham, NC, was conducted from August 6 to August 9, 2012. This four-day review evaluated the facility's adherence to Good Laboratory Practice (GLP) regulations, specifically Compliance Program 7348.808 for nonclinical laboratories. The inspection encompassed a review of three toxicology studies, laboratory operations, electronic data capturing systems, and various standard operating procedures. A key focus was assessing the company's response to verbal observations from a prior May 2010 inspection. These earlier concerns involved ensuring raw data was properly initialed and signed by the study director, accurate recording of time and temperature conditions, and timely archiving of study records. The August 2012 inspection concluded without any new observations or objectionable conditions, confirming that GlaxoSmithKline had successfully corrected the previously identified deficiencies, including an updated procedure for study record archiving. Consequently, no Form FDA 483, Inspectional Observations, was issued, and no specific corrective actions were mandated. Management was, however, reminded of their continuous responsibility to uphold all applicable GLP regulations.

Company
GlaxoSmithKline LLC
Inspection date
August 9, 2012
Product type
RX (Prescription)
Office
Office of Scientific Investigations
People
  • Nicole Taylor (company_representative)
  • Nicole M. Bell (issuing_officer)
  • Rebecca J. Pezzoni (company_representative)
  • Nancy Gongliewski (company_representative)
  • Donna L. Cooper (company_representative)
View Company Profile

ID · 7552b94f-49df-400e-aa75-b62fdb80583f

Other documents for GlaxoSmithKline LLC
  • EIR - 2016-07-15July 15, 2016
  • EIR - 2015-04-10April 10, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlaxoSmithKline LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.